Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.48 |
| ▸ | HTR1A | P08908 | 3/20 | 0.47 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.47 |
| ▸ | MAOB | P27338 | 3/20 | 0.44 |
| ▸ | DRD2 | P14416 | 3/20 | 0.44 |
| ▸ | HTR2A | P28223 | 2/20 | 0.43 |
| ▸ | HTR7 | P34969 | 1/20 | 0.43 |
| ▸ | HTR6 | P50406 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7490567 | 0.84 | HRH3 (0.49) | HRH3HTR1AMAOBDRD2HTR2A | |
| SCHEMBL7488508 | 0.82 | HRH3 (0.51) | HRH3HTR1AMAOBDRD2HTR2A | |
| SCHEMBL7485995 | 0.73 | HTR1A (0.54) | HRH3HTR1AMAOBDRD2HTR2A | |
| SCHEMBL7488037 | 0.72 | HTR1A (0.53) | HRH3HTR1AMAOBDRD2HTR2A | |
| SCHEMBL7488133 | 0.71 | HTR1A (0.50) | HRH3HTR1AABCB1HTR7 | |
| SCHEMBL26492991 | 0.67 | HTR1A (0.65) | HRH3HTR1ADRD2HTR2AHTR7 | |
| SCHEMBL26108581 | 0.67 | HTR1A (0.65) | HRH3HTR1ADRD2HTR2AHTR7 | |
| Hydrochloric Acid SCHEMBL10561281 | 0.66 | HTR1A (0.61) | HTR1ADRD2HTR2AHTR7 | |
| Hydrochloric Acid SCHEMBL26108377 | 0.66 | DRD2 (0.63) | HTR1ADRD2HTR2A | |
| Fumaric Acid SCHEMBL7488718 | 0.65 | HRH3 (0.49) | HRH3HTR1AMAOBDRD2HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1023287-B1 | 3-OXO-2(H)-1,2,4-TRIAZINE DERIVATIVES AS LIGANDS OF 5HT1A RECEPTORS | PF MEDICAMENT (FR) | 2002-06-12 | — | — | EP | claimed |
| US-6303603-B1 | FOR THEARPY OF ANXIETY, DEPRESSION, SCHIZOPHRENIA | PIERRE FABRE MEDICAMENT (FR) | 2001-10-16 | — | — | US | claimed |
| EP-1023287-B1 | 3-OXO-2(H)-1,2,4-TRIAZINE DERIVATIVES AS LIGANDS OF 5HT1A RECEPTORS | PF MEDICAMENT (FR) | 2002-06-12 | — | — | EP | disclosed |
| US-6303603-B1 | FOR THEARPY OF ANXIETY, DEPRESSION, SCHIZOPHRENIA | PIERRE FABRE MEDICAMENT (FR) | 2001-10-16 | — | — | US | disclosed |
| EP-1023287-A1 | 3-OXO-2(H)-1,2,4-TRIAZINE DERIVATIVES AS LIGANDS OF 5HT1A RECEPTORS | PIERRE FABRE MEDICAMENT (FR) | 2000-08-02 | — | — | EP | disclosed |
| WO-1999020622-A1 | 3-OXO-2(H)-1,2,4-TRIAZINE DERIVATIVES AS LIGANDS OF 5HT1A RECEPTORS | PIERRE FABRE MEDICAMENT (FR) | 1999-04-29 | — | — | WO | disclosed |